TAMING THE NEURO ICU
I wanted to let you know about a website for patients and families experiencing New Onset Refractory Status Epilepticus (NORSE) called http://www.norseinstitute.org/. This is a privately funded organization that includes some value resources including an example of a diagnostic algorithm (might look familiar to those of you who’ve seen a similar one from a few years ago!) and patient resources including …….
Advanced practice providers (APPs) are a growing part of the critical care team and play a crucial role in the care of approximately 6 million patients admitted to intensive care units annually [1]. Multiple studies support the quality care that advanced practice provide in these settings [2] and it is imperative that APPs continue to meet standards of care in these settings. This includes staying up-to-date on technology guiding practice change including Point-of-care ultrasound (POCUS).
New Forced Air Warming Criteria in Protocols section
(New) Guidelines for the Provision and Assessment of Nutrition Support Therapy in Guidelines Section
It’s here. Time to learn. Please see the COVID19 Section on TamingtheNeuroICU menu here:
In 2002, two landmark clinical trials published back-to-back in the New England Journal of Medicine (Bernard and HACA), building upon animal models that showed a neuroprotective benefit to hypothermia after cardiac arrest, set the bar for post-cardiac arrest care in the new millennium. Practice patterns changed rapidly as intensivists and hospital systems attempted to replicate their results, with greater than 50% of their patients in the 33C hypothermia arm of each trial achieving a good neurological outcome.
Central venous catheters (CVCs) are widely used in the resuscitation and treatment of critically ill and injured patients. Standard practice necessitates verification of line placement when inserted above the diaphragm. This has traditionally been accomplished in most institutions by use of post-insertion chest radiography, which will both identify the tip of the catheter at the cavoatrial junction and rule out pneumothorax ipsilateral to the insertion site.